Pfizer Ireland launched an action against a Taiwanese drug store alleging infringement of its Viagra patent number 083372 by selling generic drugs for curing erectile dysfunction. The ‘372 patent was supposed to expire on May 12, 2014, but was extended to July 2, 2016. Pfizer sought an injunction on sales of the allegedly infringing drugs as well as monetary damages. The respondent argued that Pfizer did not have standing to sue. In the judgment, the court dismissed Pfizer’s claims.